VITAS Net Revenue: $391.4 million, an increase of 17.3% year-over-year. VITAS Admissions: 16,775, a 6.3% increase from the prior year. Average Daily Census (ADC) for VITAS: 21,785 patients, a 15.5% ...
Chemed’s CHE Roto-Rooter business has been registering robust performance over the past few quarters. A good solvency position buoys optimism. The company currently carries a Zacks Rank #2 (Buy). Over ...
Hosted on MSN
CHE Q1 Earnings Call: Acquisition-Driven Growth and Medicare Cap Strategy Shape Outlook
Healthcare services company Chemed Corporation (NYSE:CHE) in Q1 CY2025, with sales up 9.8% year on year to $646.9 million. Its non-GAAP profit of $5.63 per share was 1.5% above analysts’ consensus ...
Chemed Corporation CHE reported adjusted earnings per share (EPS) of $5.32 in the third quarter of 2023, up 24.9% year over year. The figure also surpassed the Zacks Consensus Estimate by 8.1%. The ...
VITAS Net Revenue: $407.7 million in Q3 2025, a 4.2% increase from the prior year. Roto-Rooter Revenue Increase: 1.1% in Q3 2025 compared to Q3 2024. VITAS Adjusted EBITDA: $70.4 million, a 3.8% ...
On Aug 11, we issued an updated research report on Chemed Corporation CHE. The company currently operates two wholly-owned subsidiaries — VITAS Healthcare and Roto-Rooter. Over the past six months, ...
installation, repair and replacement needs including: sewers and drains, faucets, sinks, toilets, showers & tubs, waterlines, pipework, disposers, dishwashers, water heaters and septic tanks.
On Aug 11, we issued an updated research report on Chemed Corporation CHE. The company currently operates two wholly-owned subsidiaries — VITAS Healthcare and Roto-Rooter. Over the past six months, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback